A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries

Overview of attention for article published in Cost Effectiveness and Resource Allocation, August 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#50 of 533)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet

policy: 2 policy sources

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 116 Mendeley

Summary News Policy documents Dimensions citations

So far, Altmetric has seen 1 news story.

Cost-effectiveness of Nivolumab in Patients With NSCLC in the United States

AJMC, 24 Aug 2021

Study Design: Trial- and cohort-based cost-effectiveness analyses. Methods: The analyses used partitioned survival models with…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.